On the feasibility of producing Lu-177 in the IEA-R1 reactor via the direct route
Carregando...
Data
Data de publicação
2019
Orientador
Título da Revista
ISSN da Revista
Título do Volume
É parte de
É parte de
É parte de
É parte de
INTERNATIONAL NUCLEAR ATLANTIC CONFERENCE
Exportar
Resumo
Over the last years the 177Lu radioisotope has attracted great interest for the use in therapeutic and
diagnostic procedures simultaneously, being what is now called a theranostic radioisotope. There are
mainly two ways of producing this radioisotope, by direct neutron capture in a 176Lu target (the \direct
route") or by irradiating a 176Yb sample, producing 177Yb that will then decay to 177Lu (also referred
as the \indirect route"). In this work the feasibility of producing 177Lu in the IEA-R1 nuclear reactor
via the direct route was assessed, and the speci c activity that could be obtained was estimated both
experimentally and theoretically, allowing for a discussion on the feasibility of commercially producing
177Lu by 176Lu neutron capture in the IEA-R1 reactor.
Como referenciar
GENEZINI, FREDERICO A.; ZAHN, GUILHERME S.; SILVA, PAULO S.C. da; NORY, RENATA M.; MOREIRA, EDSON G.; SANTIAGO, PAULO S. On the feasibility of producing Lu-177 in the IEA-R1 reactor via the direct route. In: INTERNATIONAL NUCLEAR ATLANTIC CONFERENCE, October 21-25, 2019, Santos, SP. Proceedings... Rio de Janeiro: Associação Brasileira de Energia Nuclear, 2019. p. 1759-1765. Disponível em: http://repositorio.ipen.br/handle/123456789/30580. Acesso em: 30 Dec 2025.
Esta referência é gerada automaticamente de acordo com as normas do estilo IPEN/SP (ABNT NBR 6023) e recomenda-se uma verificação final e ajustes caso necessário.